Abstract
With increasing international travel and migration, tropical and infectious diseases once largely confined to specialist institutes now present more widely. Amoebiasis is a potentially dangerous example since it may closely mimic the presentation of inflammatory bowel disease. Misdiagnosis and treatment with immunosuppressants can result in fulminant amoebiasis and death. This review considers the epidemiology, pathogenesis, clinical features, diagnosis and treatment of intestinal and extraintestinal amoebiasis. It is written primarily for gastroenterologists, surgeons and acute physicians.
| Original language | English |
|---|---|
| Pages (from-to) | 37-50 |
| Number of pages | 14 |
| Journal | Frontline Gastroenterology |
| Volume | 16 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 9 Dec 2024 |
Bibliographical note
Publisher Copyright:© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- DIARRHOEA
- IBD
- INFECTIVE COLITIS
Fingerprint
Dive into the research topics of 'Recent advances in the diagnosis and management of amoebiasis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver